Protumor vs Antitumor Functions of IL-17
Inflammation appears to be a necessity for both metastasis and elimination of tumor cells. IL-17, a proinflammatory cytokine produced by Th17 cells, contributes to both the processes by playing a dual role in the antitumor immunity. On one hand, IL-17 promotes an antitumor cytotoxic T cell response...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 2009-10, Vol.183 (7), p.4169-4175 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4175 |
---|---|
container_issue | 7 |
container_start_page | 4169 |
container_title | The Journal of immunology (1950) |
container_volume | 183 |
creator | Murugaiyan, Gopal Saha, Bhaskar |
description | Inflammation appears to be a necessity for both metastasis and elimination of tumor cells. IL-17, a proinflammatory cytokine produced by Th17 cells, contributes to both the processes by playing a dual role in the antitumor immunity. On one hand, IL-17 promotes an antitumor cytotoxic T cell response leading to tumor regression. On the other hand, by facilitating angiogenesis and egress of tumor cells from the primary focus, IL-17 promotes tumor growth. Thus, the therapeutic application that uses IL-17 needs to be refined by minimizing its protumor functions. |
doi_str_mv | 10.4049/jimmunol.0901017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67659889</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67659889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-45d8ab14591ada73c1c8179e49687386aebb0ec50f7ba7eb6650885c879c1e023</originalsourceid><addsrcrecordid>eNpFkD1PwzAURS0EoqWwM6FMwJLynPhzrCoKlSLBALPluA5NlcTFToj49wQliOnpPp17h4PQNYYlASIfDmVdd42rliABA-YnaI4phZgxYKdoDpAkMeaMz9BFCAcAYJCQczTDcnhSxubo_tW7tqudj75CtGracgybrjFt6ZoQuSLaZsPIJTordBXs1XQX6H3z-LZ-jrOXp-16lcWGpLyNCd0JnWNCJdY7zVODjcBcWiKZ4Klg2uY5WEOh4LnmNmeMghDUCC4NtpCkC3Q77h69--xsaFVdBmOrSjfWdUExzqgUQg4gjKDxLgRvC3X0Za39t8Kgfu2oPztqsjNUbqbtLq_t7r8w6RiAuxHYlx_7vvRWhVpX1YBj1fc9FqniimAm0x86AG33</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67659889</pqid></control><display><type>article</type><title>Protumor vs Antitumor Functions of IL-17</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Murugaiyan, Gopal ; Saha, Bhaskar</creator><creatorcontrib>Murugaiyan, Gopal ; Saha, Bhaskar</creatorcontrib><description>Inflammation appears to be a necessity for both metastasis and elimination of tumor cells. IL-17, a proinflammatory cytokine produced by Th17 cells, contributes to both the processes by playing a dual role in the antitumor immunity. On one hand, IL-17 promotes an antitumor cytotoxic T cell response leading to tumor regression. On the other hand, by facilitating angiogenesis and egress of tumor cells from the primary focus, IL-17 promotes tumor growth. Thus, the therapeutic application that uses IL-17 needs to be refined by minimizing its protumor functions.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.0901017</identifier><identifier>PMID: 19767566</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Animals ; Humans ; Interleukin-17 - biosynthesis ; Interleukin-17 - physiology ; Interleukin-17 - secretion ; Neoplasms - immunology ; Neoplasms - metabolism ; Neoplasms - prevention & control ; T-Lymphocytes, Helper-Inducer - immunology ; T-Lymphocytes, Helper-Inducer - metabolism ; T-Lymphocytes, Helper-Inducer - secretion</subject><ispartof>The Journal of immunology (1950), 2009-10, Vol.183 (7), p.4169-4175</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-45d8ab14591ada73c1c8179e49687386aebb0ec50f7ba7eb6650885c879c1e023</citedby><cites>FETCH-LOGICAL-c437t-45d8ab14591ada73c1c8179e49687386aebb0ec50f7ba7eb6650885c879c1e023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19767566$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murugaiyan, Gopal</creatorcontrib><creatorcontrib>Saha, Bhaskar</creatorcontrib><title>Protumor vs Antitumor Functions of IL-17</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>Inflammation appears to be a necessity for both metastasis and elimination of tumor cells. IL-17, a proinflammatory cytokine produced by Th17 cells, contributes to both the processes by playing a dual role in the antitumor immunity. On one hand, IL-17 promotes an antitumor cytotoxic T cell response leading to tumor regression. On the other hand, by facilitating angiogenesis and egress of tumor cells from the primary focus, IL-17 promotes tumor growth. Thus, the therapeutic application that uses IL-17 needs to be refined by minimizing its protumor functions.</description><subject>Animals</subject><subject>Humans</subject><subject>Interleukin-17 - biosynthesis</subject><subject>Interleukin-17 - physiology</subject><subject>Interleukin-17 - secretion</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - prevention & control</subject><subject>T-Lymphocytes, Helper-Inducer - immunology</subject><subject>T-Lymphocytes, Helper-Inducer - metabolism</subject><subject>T-Lymphocytes, Helper-Inducer - secretion</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkD1PwzAURS0EoqWwM6FMwJLynPhzrCoKlSLBALPluA5NlcTFToj49wQliOnpPp17h4PQNYYlASIfDmVdd42rliABA-YnaI4phZgxYKdoDpAkMeaMz9BFCAcAYJCQczTDcnhSxubo_tW7tqudj75CtGracgybrjFt6ZoQuSLaZsPIJTordBXs1XQX6H3z-LZ-jrOXp-16lcWGpLyNCd0JnWNCJdY7zVODjcBcWiKZ4Klg2uY5WEOh4LnmNmeMghDUCC4NtpCkC3Q77h69--xsaFVdBmOrSjfWdUExzqgUQg4gjKDxLgRvC3X0Za39t8Kgfu2oPztqsjNUbqbtLq_t7r8w6RiAuxHYlx_7vvRWhVpX1YBj1fc9FqniimAm0x86AG33</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Murugaiyan, Gopal</creator><creator>Saha, Bhaskar</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20091001</creationdate><title>Protumor vs Antitumor Functions of IL-17</title><author>Murugaiyan, Gopal ; Saha, Bhaskar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-45d8ab14591ada73c1c8179e49687386aebb0ec50f7ba7eb6650885c879c1e023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Humans</topic><topic>Interleukin-17 - biosynthesis</topic><topic>Interleukin-17 - physiology</topic><topic>Interleukin-17 - secretion</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - prevention & control</topic><topic>T-Lymphocytes, Helper-Inducer - immunology</topic><topic>T-Lymphocytes, Helper-Inducer - metabolism</topic><topic>T-Lymphocytes, Helper-Inducer - secretion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murugaiyan, Gopal</creatorcontrib><creatorcontrib>Saha, Bhaskar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murugaiyan, Gopal</au><au>Saha, Bhaskar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protumor vs Antitumor Functions of IL-17</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>183</volume><issue>7</issue><spage>4169</spage><epage>4175</epage><pages>4169-4175</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>Inflammation appears to be a necessity for both metastasis and elimination of tumor cells. IL-17, a proinflammatory cytokine produced by Th17 cells, contributes to both the processes by playing a dual role in the antitumor immunity. On one hand, IL-17 promotes an antitumor cytotoxic T cell response leading to tumor regression. On the other hand, by facilitating angiogenesis and egress of tumor cells from the primary focus, IL-17 promotes tumor growth. Thus, the therapeutic application that uses IL-17 needs to be refined by minimizing its protumor functions.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>19767566</pmid><doi>10.4049/jimmunol.0901017</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2009-10, Vol.183 (7), p.4169-4175 |
issn | 0022-1767 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_67659889 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Humans Interleukin-17 - biosynthesis Interleukin-17 - physiology Interleukin-17 - secretion Neoplasms - immunology Neoplasms - metabolism Neoplasms - prevention & control T-Lymphocytes, Helper-Inducer - immunology T-Lymphocytes, Helper-Inducer - metabolism T-Lymphocytes, Helper-Inducer - secretion |
title | Protumor vs Antitumor Functions of IL-17 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A12%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protumor%20vs%20Antitumor%20Functions%20of%20IL-17&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Murugaiyan,%20Gopal&rft.date=2009-10-01&rft.volume=183&rft.issue=7&rft.spage=4169&rft.epage=4175&rft.pages=4169-4175&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.0901017&rft_dat=%3Cproquest_cross%3E67659889%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67659889&rft_id=info:pmid/19767566&rfr_iscdi=true |